Literature DB >> 11763348

Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers.

D A Stein1, D E Skilling, P L Iversen, A W Smith.   

Abstract

Caliciviruses infect and cause disease in animals and humans. They are nonenveloped, positive-stranded RNA viruses with a genome of approximately 7.5 kb that encodes viral proteins in three open reading frames (ORF). Antisense oligomers targeting one of the three ORF of caliciviruses of the genus Vesivirus significantly inhibit viral replication in tissue culture. Porcine kidney and African green monkey kidney cells were infected with Vesivirus isolates SMSV-13 and PCV Pan-1. Phosphorodiamidate morpholino oligomers (PMO) with sequence complementary to the AUG translation start site regions of ORF1, ORF2, and ORF3 were evaluated for their effect on viral titer. Scrape-loading delivered PMO to 50%-70% of the cells of the two cell lines, as measured by fluorescence microscopy and flow cytometry. A PMO targeting ORF3 caused a significant increase in viral titer. A PMO targeting ORF2, a scrambled PMO control sequence, and an unrelated PMO antisense sequence did not alter viral titer. Various PMO sequences antisense to an upstream region of ORF1 were effective in reducing viral titer up to 80% in a dose-dependent and sequence-specific manner. The extent of viral titer reduction was proportional to the delivery of PMO to cells. These observations demonstrate that antisense PMO can disrupt caliciviral gene function in a nucleic acid sequence-specific manner and are potentially effective antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11763348     DOI: 10.1089/108729001753231696

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  17 in total

1.  Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.

Authors:  Richard M Kinney; Claire Y-H Huang; Becky C Rose; Andrew D Kroeker; Theo W Dreher; Patrick L Iversen; David A Stein
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.

Authors:  Qing Ge; Manoj Pastey; Darwyn Kobasa; Piliapan Puthavathana; Christopher Lupfer; Richard K Bestwick; Patrick L Iversen; Jianzhu Chen; David A Stein
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

3.  Inhibition of Tulane virus replication in vitro with RNA interference.

Authors:  Qiang Fan; Chao Wei; Ming Xia; Xi Jiang
Journal:  J Med Virol       Date:  2013-01       Impact factor: 2.327

4.  Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth.

Authors:  Benjamin W Neuman; David A Stein; Andrew D Kroeker; Amy D Paulino; Hong M Moulton; Patrick L Iversen; Michael J Buchmeier
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.

Authors:  Sven Enterlein; Kelly L Warfield; Dana L Swenson; David A Stein; Jeffery L Smith; C Scott Gamble; Andrew D Kroeker; Patrick L Iversen; Sina Bavari; Elke Mühlberger
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.

Authors:  Dana L Swenson; Kelly L Warfield; Travis K Warren; Candace Lovejoy; Jed N Hassinger; Gordon Ruthel; Robert E Blouch; Hong M Moulton; Dwight D Weller; Patrick L Iversen; Sina Bavari
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Authors:  Kelly L Warfield; Dana L Swenson; Gene G Olinger; Donald K Nichols; William D Pratt; Robert Blouch; David A Stein; M Javad Aman; Patrick L Iversen; Sina Bavari
Journal:  PLoS Pathog       Date:  2006-01-13       Impact factor: 6.823

8.  Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.

Authors:  Yan-Jin Zhang; Kai-Yu Wang; David A Stein; Deendayal Patel; Rheba Watkins; Hong M Moulton; Patrick L Iversen; David O Matson
Journal:  Antiviral Res       Date:  2006-06-14       Impact factor: 5.970

9.  Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.

Authors:  Patrick L Iversen; Travis K Warren; Jay B Wells; Nicole L Garza; Dan V Mourich; Lisa S Welch; Rekha G Panchal; Sina Bavari
Journal:  Viruses       Date:  2012-11-06       Impact factor: 5.048

10.  Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome.

Authors:  Karin Bok; Victoria J Cavanaugh; David O Matson; Lorenzo González-Molleda; Kyeong-Ok Chang; Carmelann Zintz; Alvin W Smith; Patrick Iversen; Kim Y Green; Ann E Campbell
Journal:  Virology       Date:  2008-09-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.